๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

High levels of serum angiogenic growth factors in patients with AL amyloidosis: comparisons with normal individuals and multiple myeloma patients

โœ Scribed by Efstathios Kastritis; Maria Roussou; Michalis Michael; Maria Gavriatopoulou; Evridiki Michalis; Magdalini Migkou; Sossana Delimpasi; Marie Christine Kyrtsonis; Dimitrios Gogos; Konstantinos Liapis; Evangelia Charitaki; Panagiotis Repousis; Evangelos Terpos; Meletios A. Dimopoulos; On behalf of the Greek Myeloma Study Group

Book ID
108676878
Publisher
John Wiley and Sons
Year
2010
Tongue
English
Weight
133 KB
Volume
150
Category
Article
ISSN
0007-1048

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

The combination of intermediate doses of
The combination of intermediate doses of thalidomide and dexamethasone reduces bone marrow micro-vessel density but not serum levels of angiogenic cytokines in patients with refractory/relapsed multiple myeloma
โœ E. Hatjiharissi; E. Terpos; M. Papaioannou; C. Hatjileontis; V. Kaloutsi; G. Gal ๐Ÿ“‚ Article ๐Ÿ“… 2004 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 288 KB

## Abstract The aim of the study was the evaluation of antiโ€angiogenic activity of the combination of intermediate doses of thalidomide and dexamethasone in patients with refractory/relapsed myeloma. Twentyโ€five patients were included in the study. Microvessel density (MVD) was evaluated in marrow